Advocacy intelligence hub — real-time data for patient organizations
Cayston: FDA approved
To improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Cayston
Gilead Sciences, Inc.
Cayston
(aztreonam)Orphan drugGilead Sciences, Inc.
12.1 Mechanism of Action Aztreonam is an antibacterial drug [see Clinical Pharmacology (12.4) ] .